Category Archives: social media

Chats Not Charts: Three Steps to Pharma Post-Marketing

by Andrew Spong (originally published on stwem.com) The air of despondency that is descending over the pharmaceutical industry’s use of social media is perverse. It has nothing to do with a putative (and also fictive) absence of interest on the patient’s part in connecting with the pharmaceutical industry. It has everything to do with the […]
Also posted in Advertising, E-Media, Guest Blog, leadership, Marketing, Patient Communication, patient education, Strategy | Leave a comment

Pharma Marketers: Avoid the Tactical Scrum

by Al Topin With the introduction of every new technology, tactic, or gimmick comes what I call a tactical scrum. It’s like watching young kids play their first game of T-ball or soccer. No matter how much instruction the coach gives on field position or game play, the second that ball is hit or kicked, […]
Also posted in Advertising, Agency Insight, E-Media, Guest Blog, Marketing, People, Sales, Strategy, Technology | Tagged , , , | Leave a comment

Making the Most of Disruptive Digital Technologies

Peter Houston looks at the pharma marketing takeaways from last week’s Digital Innovation Summit.
Also posted in E-Media, Europe, Events, Global, Marketing, multimedia, Op-Ed, Technology | Tagged , , , | Leave a comment

The Rise of the Patient Participant

Either the doctor’s best friend or nightmare, the e-patient movement (the ‘e’ could stand for engaged or empowered) is here to stay and growing, writes Marylyn Donahue. Championing patients as full partners in their own medical care, via the use of online communities and social media sites are slowly but surely turning patients into participants […]
Also posted in E-Media, healthcare, Medical Education, multimedia, Patient Communication, patient education, Technology | Tagged , , , | Leave a comment

Social Media Raise Concerns for Marketers, Trial Sponsors

While biopharmaceutical companies are using websites and third-party postings to provide information on medical products — despite a host of regulatory issues — social media use is in its infancy related to the design and conduct of clinical trials. A recent report from the Tufts Center for the Study of Drug Development (http://csdd.tufts.edu) finds that […]
Also posted in FDA, Regulatory | Tagged , , , , , | Leave a comment
  • Categories

  • Meta